It is generally recognised that early diagnosis significantly improves cancer survival rates; advances in technology are leading to achieving that desirable outcome. The Cancer Diagnostic Technology Summit 2022 provides a platform for leading developers to showcase the current and future directions of technology in cancer diagnosis. The Conference will explore advances in a range of diagnostic methodologies, and concerns that very early diagnosis may lead to treatment of biologically insignificant cancers.
Blood biopsy
Biomarkers in breath, saliva and urine
Cell separation and DNA sequencing
AI in imaging and data mining
Prof. H Thomas Aretz MD, Harvard Medical School
Dr. Michael Brand, Sensor100
Dr. Kalypso Charalambous, Imperial College
Dr. Pedro Estrela, University of Bath
 |
 |
 |
